<?xml version="1.0" encoding="UTF-8"?>
<p>Atazanavir (methyl N-[(2R)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2R)-2-(methoxycarbonylamino)-3,3-di-methylbutanoyl]amino]-4-(2,3,4,5,6-pentadeuteriophenyl)butyl]-2-[(4-pyridin-2-ylphenyl)methyl]hy-drazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate) was licensed by the FDA in 2003 and is also used as an anti-HIV compound. Similar to lopinavir, some efficacy of atazanavir was shown against FIV 
 <italic>in vitro</italic>, but there are no 
 <italic>in vivo</italic> studies published so far [
 <xref rid="B85-vetsci-02-00456" ref-type="bibr">85</xref>].
</p>
